Lexicon Pharmaceuticals LXRX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$26.09M+48.2% | -$50.34M+26.6% | -$68.58M+43.1% | -$120.62M+32.0% | -$177.3M+11.5% | ||
| $555K-10.6% | $621K-1.1% | $628K+4.1% | $603K+6.5% | $566K+6.0% | ||
| $12.55M+0.3% | $12.52M+11.6% | $11.22M+6.1% | $10.58M-13.6% | $12.24M-9.3% | ||
| —— | —— | —— | —— | -$167.43M+6.3% | ||
| $2.18M-98.1% | $113.02M— | —— | —— | —— | ||
| $53M+10.4% | $48M+6.7% | $45M0.0% | $45M— | —— | ||
| $40.83M+184% | -$48.5M— | —— | —— | —— | ||
| $4.2M+226% | -$3.33M-108% | $44.11M— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Lexicon Pharmaceuticals generate?
- Lexicon Pharmaceuticals (LXRX) generated -$99.6M in operating cash flow over the trailing twelve months.
- Where does Lexicon Pharmaceuticals's cash flow data come from?
- Every line is extracted from Lexicon Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
